Literature DB >> 6491668

Histamine turnover in the brain of different mammalian species: implications for neuronal histamine half-life.

M Nishibori, R Oishi, K Saeki.   

Abstract

The turnover of neuronal histamine (HA) in nine brain regions and the spinal cord of the guinea pig and the mouse was estimated and the values obtained were compared with data previously obtained in rats. The size of the neuronal HA pool was determined from the decrease in HA content, as induced by (S)-alpha-fluoro-methylhistidine (alpha-FMH), a suicide inhibitor of histidine decarboxylase. The ratios of neuronal HA to the total differed with the brain region. Pargyline hydrochloride increased the tele-methylhistamine (t-MH) levels linearly up to 2 h after administration in both the guinea pig and the mouse whole brain. Regional differences in the turnover rate of neuronal HA, calculated from the pargyline-induced accumulation of t-MH, as well as in the size of the neuronal HA pool, were more marked in the mouse than in the guinea pig brain. The hypothalamus showed the highest rate in both species. There was a good correlation between the steady-state t-MH levels and the turnover rate in different brain regions. Neither the elevation of the t-MH levels by pargyline nor the reduction of HA by alpha-FMH was observed in the spinal cord, thereby suggesting that the HA present in this region is of mast cell origin. The half-life of neuronal HA in different brain regions was in the range of 13-38 min for the mouse and 24-37 min for the guinea pig, except for HA from the guinea pig hypothalamus, which had an extraordinarily long value of 87 min. These results suggest that there are species differences in the function of the brain histaminergic system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491668     DOI: 10.1111/j.1471-4159.1984.tb06076.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Histamine turnover in the brain of morphine-dependent mice.

Authors:  R Oishi; M Nishibori; Y Itoh; K Saeki; T Fukuda; Y Araki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

2.  Regional characteristics of histamine uptake into neonatal rat astrocytes.

Authors:  Katja Perdan-Pirkmajer; Sergej Pirkmajer; Andreja Raztresen; Mojca Krzan
Journal:  Neurochem Res       Date:  2013-04-03       Impact factor: 3.996

3.  High levels of histidine decarboxylase in the striatum of mice and rats.

Authors:  Kuakarun Krusong; A Gulhan Ercan-Sencicek; Meiyu Xu; Hiroshi Ohtsu; George M Anderson; Matthew W State; Christopher Pittenger
Journal:  Neurosci Lett       Date:  2011-04-01       Impact factor: 3.046

4.  Diurnal fluctuation in levels of histamine metabolites in cerebrospinal fluid of rhesus monkey.

Authors:  G D Prell; J K Khandelwal; R S Burns; J P Green
Journal:  Agents Actions       Date:  1989-03

5.  Signal transduction by histamine in the cerebellum and its modulation by N-methyltransferase.

Authors:  Motohiko Takemura; Nobue Kitanaka; Junichi Kitanaka
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 6.  Measurement of histamine metabolites in brain and cerebrospinal fluid provides insights into histaminergic activity.

Authors:  G D Prell; J P Green
Journal:  Agents Actions       Date:  1994-06

7.  Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.

Authors:  C R Calcutt; C R Ganellin; R Griffiths; B K Leigh; J P Maguire; R C Mitchell; M E Mylek; M E Parsons; I R Smith; R C Young
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

8.  Comparison of the size of neuronal and non-neuronal histamine pools in the brain of different rat strains.

Authors:  R Oishi; Y Itoh; T Fukuda; Y Araki; K Saeki
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

9.  A mathematical model for histamine synthesis, release, and control in varicosities.

Authors:  Janet Best; H F Nijhout; Srimal Samaranayake; Parastoo Hashemi; Michael Reed
Journal:  Theor Biol Med Model       Date:  2017-12-12       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.